Mark Redshaw is an Investment Director at Evonik Venture Capital. Where he focuses on deals relating to nutrition, health and care, and specialty additives. Mark holds board seats at a number of portfolio companies. Prior to joining the team founding Evonik Venture Capital in 2012, Mark held positions within the Nutrition & Care business of Evonik. With over 15 years in international operational roles in a dynamic growing global business. This included time responsible for sustainability, heading the Evonik’s global Animal Nutrition Services and running the operative business in Africa and the Middle East. Mark studied agriculture at the University of Reading and received a PhD from the University of Nottingham.